期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 46, 期 10, 页码 2286-2301出版社
WILEY
DOI: 10.1002/eji.201546178
关键词
Aging; B lymphocytes; Longevity; NK cells; Signaling; T lymphocytes; Vaccine
类别
资金
- Fondazione Cassa di Risparmio di Vignola (Italy)
- French Agence Nationale de la Recherche (ANR) [ANR-14-CE14-0030-01]
- Fondation Recherche Medicale [DEQ20120323690]
- NIH [R21 AI096446, R21 AG042826, R56 AG032576]
- Canadian Institutes of Health Research (CIHR) [106634, 106701]
- Universite de Sherbrooke
- Research Center on Aging
- SIgN
- Agency for Science Technology and Research (JCO DP) [1434m00115, SRIS SRG/14018]
- European Union [280873 ADITEC]
- Ministero dell'Istruzione, Universita, Ricerca (MIUR) [RBAP11S8C3]
Major advances in preventing, delaying, or curing individual pathologies are responsible for an increasingly long life span in the developed parts of our planet, and indeed reaching eight to nine decades of life is nowadays extremely frequent. However, medical and sanitary advances have not prevented or delayed the underlying cause of the disparate pathologies occurring in the elderly: aging itself. The identification of the basis of the aging processes that drives the multiple pathologies and loss of function typical of older individuals is a major challenge in current aging research. Among the possible causes, an impairment of the immune system plays a major role, and indeed numerous studies have described immunological changes which occur with age. Far from the intention of being exhaustive, this review will focus on recent advances and views on the role that modifications of cell signalling and remodelling of the immune response play during human aging and longevity, paying particular attention to phenomena which are linked to the so called inflammaging process, such as dysregulation of innate immunity, altered T-cell or B-cell maturation and differentiation, as well as to the implications of immune aging for vaccination strategies in the elderly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据